Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
bovine FSH superagonist
- Development stage
- Unknown
- Lead developer
- Trophogen
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Subcutaneous, Intramuscular
01
Overview
Bovine FSH superagonist is a recombinant protein analog of follicle-stimulating hormone (FSH) designed to activate the follicle-stimulating hormone receptor (FSHR) with enhanced potency and prolonged biological activity compared to standard pituitary-derived or recombinant FSH preparations. Developed by Trophogen and licensed to Zoetis for veterinary applications, the drug utilizes superagonist technology to stimulate ovarian follicular development and superovulation. It is being investigated for use in human reproductive medicine to treat infertility and in veterinary medicine to improve the efficiency of embryo transfer protocols in beef and dairy cattle. The molecule is engineered to have increased binding affinity and signaling efficacy at the FSH receptor, potentially allowing for reduced dosing frequency and improved clinical outcomes in assisted reproductive technologies.
- Other names
- recombinant bovine FSH superagonistrbFSH superagonistbFSH superagonistbovine FSH superagonist (animal)
02
Targets
FSHR (Follicle-stimulating hormone receptor)
Beyond the preview
Go deeper on bovine FSH superagonist.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on bovine FSH superagonist.